Assignee
BIOTHERYX INC
US·34 granted patents·16 pending applications·68 citations·filing 2012–2024
Top patents by PatentIndex Score
50 records- 0195US10144745B2Chimeric compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2017·Granted Dec 4, 2018·15 cites·18 claims
- 0295US10040804B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2017·Granted Aug 7, 2018·17 cites·30 claims
- 0392US10889593B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2019·Granted Jan 12, 2021·4 cites·27 claims
- 0492US10336771B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Granted Jul 2, 2019·8 cites·24 claims
- 0589US10513515B2Ether compounds and uses thereofBIOTHERYX INC·Filed 2018·Granted Dec 24, 2019·4 cites·28 claims
- 0688US10406165B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Granted Sep 10, 2019·6 cites·25 claims
- 0787US10669260B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2017·Granted Jun 2, 2020·3 cites·15 claims
- 0886US10905684B2Aminoamide compoundsBIOTHERYX INC·Filed 2019·Granted Feb 2, 2021·2 cites·29 claims
- 0983US11236105B2Bicyclic compounds and methods of useBIOTHERYX INC·Filed 2020·Granted Feb 1, 2022·1 cites·22 claims
- 1082US9822098B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2016·Granted Nov 21, 2017·3 cites·22 claims
- 1180US10570147B2Bicyclic compounds and methods of useBIOTHERYX INC·Filed 2018·Granted Feb 25, 2020·2 cites·30 claims
- 1278US10844039B2Substituted isoindolinonesBIOTHERYX INC·Filed 2019·Granted Nov 24, 2020·1 cites·36 claims
- 1374US11345714B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2021·Granted May 31, 2022·0 cites·32 claims
- 1474US9527815B2Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseasesBIOTHERYX INC·Filed 2015·Granted Dec 27, 2016·2 cites·32 claims
- 1568US2024368114A1Indazoles, pharmaceutical compositions, and therapeutic applicationsBIOTHERYX INC·Filed 2024·Application pending·0 cites
- 1667US2022298172A1Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 1766US2022153751A1Bifunctional compoundsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 1865US10927104B2Ether compounds and uses thereofBIOTHERYX INC·Filed 2019·Granted Feb 23, 2021·0 cites·26 claims
- 1964US11400084B2Aminoamide compoundsBIOTHERYX INC·Filed 2021·Granted Aug 2, 2022·0 cites·21 claims
- 2064US11352338B2Substituted isoindolinonesBIOTHERYX INC·Filed 2020·Granted Jun 7, 2022·0 cites·22 claims
- 2164US2022088025A1Fused thiophene compoundsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 2264US2024190883A1Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2023·Application pending·0 cites
- 2363US12419962B2Quinazolines, pharmaceutical compositions, and therapeutic applicationsBIOTHERYX INC·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 2463US11191769B2Fused thiophene compoundsBIOTHERYX INC·Filed 2019·Granted Dec 7, 2021·0 cites·39 claims
- 2563US2025186434A1Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2023·Application pending·0 cites
- 2662US11236103B2Bifunctional compoundsBIOTHERYX INC·Filed 2019·Granted Feb 1, 2022·0 cites·33 claims
- 2762US10562917B2Chimeric compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Granted Feb 18, 2020·0 cites·22 claims
- 2861US9546131B2Substituted biaryl alkyl amidesBIOTHERYX INC·Filed 2014·Granted Jan 17, 2017·0 cites·27 claims
- 2961US9273005B2Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseasesBIOTHERYX INC·Filed 2012·Granted Mar 1, 2016·0 cites·17 claims
- 3061US2019276474A1Chimeric compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2018·Application pending·0 cites
- 3159US11345712B2Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2020·Granted May 31, 2022·0 cites·51 claims
- 3259US2024368121A1Estrogen receptor degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 3359US2024207268A1Pyrazolylpyrimidines for treating malignant solid tumorBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 3458US8822527B2Substituted biaryl alkyl amidesBIOTHERYX INC·Filed 2012·Granted Sep 2, 2014·0 cites·38 claims
- 3557US10106491B2Substituted biaryl alkyl amidesBIOTHERYX INC·Filed 2016·Granted Oct 23, 2018·0 cites·17 claims
- 3656US10857155B2Compounds targeting proteins, compositions, methods, and uses thereofBIOTHERYX INC·Filed 2019·Granted Dec 8, 2020·0 cites·9 claims
- 3756US2024124418A1Pde4 degraders, pharmaceutical compositions, and therapeutic applicationsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 3856US2024190885A1Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 3955US2023047732A1Pyrazolylpyrimidines and use thereofBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 4054US12522612B2PDE4 inhibitors, pharmaceutical compositions, and therapeutic applicationsBIOTHERYX INC·Filed 2020·Granted Jan 13, 2026·0 cites·37 claims
- 4154US11433047B2Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseasesBIOTHERYX INC·Filed 2016·Granted Sep 6, 2022·0 cites·35 claims
- 4254US2024197888A1Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 4354US2024025863A1Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 4452US10654805B2Pyridinethiones, pharmaceutical compositions thereof, and their therapeutic use for treating a proliferative, inflammatory, neurodegenerative, or immune-mediated diseaseBIOTHERYX INC·Filed 2019·Granted May 19, 2020·0 cites·26 claims
- 4552US2015342942A1Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridoneBIOTHERYX INC·Filed 2015·Application pending·0 cites
- 4650US2023002371A1Ras protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2020·Application pending·0 cites
- 4747US10233153B2Pyridinethiones, pharmaceutical compositions thereof, and their therapeutic use for treating a proliferative, inflammatory, neurodegenerative, or immune-mediated diseaseBIOTHERYX INC·Filed 2017·Granted Mar 19, 2019·0 cites·27 claims
- 4845US10584133B2Thienopyrimidinone compoundsBIOTHERYX INC·Filed 2019·Granted Mar 10, 2020·0 cites·44 claims
- 4945US10045972B2Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseasesBIOTHERYX INC·Filed 2016·Granted Aug 14, 2018·0 cites·31 claims
- 5036US9926277B2Pyridone compounds, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseasesBIOTHERYX INC·Filed 2016·Granted Mar 27, 2018·0 cites·43 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →